{"id":"https://openalex.org/W2003190574","doi":"https://doi.org/10.2165/11537560-000000000-00000","title":"Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma: A Pragmatic Trial","display_name":"Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma: A Pragmatic Trial","publication_year":2010,"publication_date":"2010-05-19","ids":{"openalex":"https://openalex.org/W2003190574","doi":"https://doi.org/10.2165/11537560-000000000-00000","mag":"2003190574","pmid":"https://pubmed.ncbi.nlm.nih.gov/20446755"},"language":"en","primary_location":{"id":"doi:10.2165/11537560-000000000-00000","doi":"https://doi.org/10.2165/11537560-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/11537560-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102772703","display_name":"Ed Wilson","orcid":"https://orcid.org/0000-0002-8369-1577","observed_orcids":["https://orcid.org/0000-0002-8369-1577"]},"institutions":[{"id":"https://openalex.org/I1118541","display_name":"University of East Anglia","ror":"https://ror.org/026k5mg93","country_code":"GB","type":"education","lineage":["https://openalex.org/I1118541"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Edward C. F. Wilson","raw_affiliation_strings":["Faculty of Health, University of East Anglia, Norwich, UK. ed.wilson@uea.ac.uk","#N#University of East Anglia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Health, University of East Anglia, Norwich, UK. ed.wilson@uea.ac.uk","institution_ids":["https://openalex.org/I1118541"]},{"raw_affiliation_string":"#N#University of East Anglia","institution_ids":["https://openalex.org/I1118541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052175038","display_name":"David Brendan Price","orcid":"https://orcid.org/0000-0002-9728-9992","observed_orcids":["https://orcid.org/0000-0002-9728-9992","https://orcid.org/0000-0002-1195-039X"]},"institutions":[{"id":"https://openalex.org/I1118541","display_name":"University of East Anglia","ror":"https://ror.org/026k5mg93","country_code":"GB","type":"education","lineage":["https://openalex.org/I1118541"]},{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Price","raw_affiliation_strings":["Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK","Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","Health Economics Group, Faculty of Health, University of East Anglia, Norwich, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK","institution_ids":["https://openalex.org/I195460627"]},{"raw_affiliation_string":"Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","institution_ids":["https://openalex.org/I1118541"]},{"raw_affiliation_string":"Health Economics Group, Faculty of Health, University of East Anglia, Norwich, UK","institution_ids":["https://openalex.org/I1118541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111968076","display_name":"Stanley D. Musgrave","orcid":"https://orcid.org/0000-0002-4626-3469","observed_orcids":["https://orcid.org/0000-0002-4626-3469"]},"institutions":[{"id":"https://openalex.org/I1118541","display_name":"University of East Anglia","ror":"https://ror.org/026k5mg93","country_code":"GB","type":"education","lineage":["https://openalex.org/I1118541"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stanley D. Musgrave","raw_affiliation_strings":["Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","#N#University of East Anglia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","institution_ids":["https://openalex.org/I1118541"]},{"raw_affiliation_string":"#N#University of East Anglia","institution_ids":["https://openalex.org/I1118541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002323416","display_name":"Erika J Sims","orcid":"https://orcid.org/0000-0002-7898-0331","observed_orcids":["https://orcid.org/0000-0002-7898-0331"]},"institutions":[{"id":"https://openalex.org/I1118541","display_name":"University of East Anglia","ror":"https://ror.org/026k5mg93","country_code":"GB","type":"education","lineage":["https://openalex.org/I1118541"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Erika J. Sims","raw_affiliation_strings":["Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","#N#University of East Anglia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","institution_ids":["https://openalex.org/I1118541"]},{"raw_affiliation_string":"#N#University of East Anglia","institution_ids":["https://openalex.org/I1118541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032021654","display_name":"Lee Shepstone","orcid":"https://orcid.org/0000-0001-5524-7818","observed_orcids":["https://orcid.org/0000-0001-5524-7818"]},"institutions":[{"id":"https://openalex.org/I1118541","display_name":"University of East Anglia","ror":"https://ror.org/026k5mg93","country_code":"GB","type":"education","lineage":["https://openalex.org/I1118541"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lee Shepstone","raw_affiliation_strings":["Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","#N#University of East Anglia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","institution_ids":["https://openalex.org/I1118541"]},{"raw_affiliation_string":"#N#University of East Anglia","institution_ids":["https://openalex.org/I1118541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000766438","display_name":"Jamie Murdoch","orcid":"https://orcid.org/0000-0002-9021-3629","observed_orcids":["https://orcid.org/0000-0002-9021-3629"]},"institutions":[{"id":"https://openalex.org/I1118541","display_name":"University of East Anglia","ror":"https://ror.org/026k5mg93","country_code":"GB","type":"education","lineage":["https://openalex.org/I1118541"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jamie Murdoch","raw_affiliation_strings":["Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","#N#University of East Anglia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","institution_ids":["https://openalex.org/I1118541"]},{"raw_affiliation_string":"#N#University of East Anglia","institution_ids":["https://openalex.org/I1118541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004884604","display_name":"H. Miranda Mugford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1118541","display_name":"University of East Anglia","ror":"https://ror.org/026k5mg93","country_code":"GB","type":"education","lineage":["https://openalex.org/I1118541"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H. Miranda Mugford","raw_affiliation_strings":["Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","#N#University of East Anglia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","institution_ids":["https://openalex.org/I1118541"]},{"raw_affiliation_string":"#N#University of East Anglia","institution_ids":["https://openalex.org/I1118541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101793652","display_name":"Annie Blyth","orcid":"https://orcid.org/0000-0001-5380-5353","observed_orcids":["https://orcid.org/0000-0001-5380-5353"]},"institutions":[{"id":"https://openalex.org/I1118541","display_name":"University of East Anglia","ror":"https://ror.org/026k5mg93","country_code":"GB","type":"education","lineage":["https://openalex.org/I1118541"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Annie Blyth","raw_affiliation_strings":["Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","#N#University of East Anglia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","institution_ids":["https://openalex.org/I1118541"]},{"raw_affiliation_string":"#N#University of East Anglia","institution_ids":["https://openalex.org/I1118541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031103832","display_name":"Elizabeth F. Juniper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98251732","display_name":"McMaster University","ror":"https://ror.org/02fa3aq29","country_code":"CA","type":"education","lineage":["https://openalex.org/I98251732"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Elizabeth F. Juniper","raw_affiliation_strings":["Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada","McMaster university#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada","institution_ids":["https://openalex.org/I98251732"]},{"raw_affiliation_string":"McMaster university#TAB#","institution_ids":["https://openalex.org/I98251732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091752071","display_name":"Jon G. Ayres","orcid":"https://orcid.org/0000-0002-3163-3674","observed_orcids":["https://orcid.org/0000-0002-3163-3674"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jon G. Ayres","raw_affiliation_strings":["Institute of Occupational and Environmental Medicine, Division of Public Health and Epidemiology, University of Birmingham, Birmingham, UK","University of Birmingham.*"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Occupational and Environmental Medicine, Division of Public Health and Epidemiology, University of Birmingham, Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"University of Birmingham.*","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009586803","display_name":"Stephanie Wolfe","orcid":"https://orcid.org/0000-0001-8344-5774","observed_orcids":["https://orcid.org/0000-0001-8344-5774"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephanie Wolfe","raw_affiliation_strings":["Thorpewood Surgery, Norwich, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thorpewood Surgery, Norwich, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064569292","display_name":"Daryl Freeman","orcid":"https://orcid.org/0000-0003-2056-2716","observed_orcids":["https://orcid.org/0000-0003-2056-2716"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Daryl Freeman","raw_affiliation_strings":["Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK","Sheringham Medical Practice, Sheringham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK","institution_ids":["https://openalex.org/I195460627"]},{"raw_affiliation_string":"Sheringham Medical Practice, Sheringham, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034825689","display_name":"R.F.T. Gilbert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard F.T. Gilbert","raw_affiliation_strings":["Castle Partnership, Norwich, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Castle Partnership, Norwich, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036290773","display_name":"Elizabeth V. Hillyer","orcid":"https://orcid.org/0000-0003-3022-5692","observed_orcids":["https://orcid.org/0000-0003-3022-5692"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth V. Hillyer","raw_affiliation_strings":["Research in Real Life Ltd, Cawston, Norwich, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research in Real Life Ltd, Cawston, Norwich, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108093072","display_name":"Ian M. Harvey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1118541","display_name":"University of East Anglia","ror":"https://ror.org/026k5mg93","country_code":"GB","type":"education","lineage":["https://openalex.org/I1118541"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ian Harvey","raw_affiliation_strings":["Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","#N#University of East Anglia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics Group, Faculty of Health, University of East Anglia, Norwich, NR4 7TJ, UK","institution_ids":["https://openalex.org/I1118541"]},{"raw_affiliation_string":"#N#University of East Anglia","institution_ids":["https://openalex.org/I1118541"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5102772703"],"corresponding_institution_ids":["https://openalex.org/I1118541"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":0.9938,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.78196837,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"28","issue":"7","first_page":"597","last_page":"608"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.6859999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.6859999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.30790001153945923,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/leukotriene-receptor-antagonists","display_name":"leukotriene receptor antagonists","score":0.968999981880188},{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.8640000224113464},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.9380000233650208},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8730000257492065},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8550000190734863},{"id":"https://openalex.org/keywords/asthma-control","display_name":"asthma control","score":0.8479999899864197},{"id":"https://openalex.org/keywords/asthma-related-quality-of-life","display_name":"asthma quality of life","score":0.7120000123977661},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.8119999766349792},{"id":"https://openalex.org/keywords/economic-evaluation","display_name":"economic evaluation","score":0.515999972820282},{"id":"https://openalex.org/keywords/pragmatic-randomized-controlled-trial","display_name":"pragmatic randomized controlled trial","score":0.5860000252723694},{"id":"https://openalex.org/keywords/social-costs","display_name":"social costs","score":0.3610000014305115},{"id":"https://openalex.org/keywords/nhs-perspective","display_name":"NHS perspective","score":0.7689999938011169},{"id":"https://openalex.org/keywords/willingness-to-pay","display_name":"willingness to pay","score":0.824999988079071},{"id":"https://openalex.org/keywords/treatment-switching","display_name":"treatment switching","score":0.36500000953674316},{"id":"https://openalex.org/keywords/uncontrolled-asthma","display_name":"uncontrolled asthma","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9058130979537964},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.7172552347183228},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.5948983430862427},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5716215968132019},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.5672821998596191},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.49174025654792786},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4842681288719177},{"id":"https://openalex.org/C3017940444","wikidata":"https://www.wikidata.org/wiki/Q287961","display_name":"B2 receptor","level":4,"score":0.460561603307724},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4584166407585144},{"id":"https://openalex.org/C515549039","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost-effectiveness analysis","level":3,"score":0.4555346965789795},{"id":"https://openalex.org/C2776125615","wikidata":"https://www.wikidata.org/wiki/Q18391886","display_name":"Economic evaluation","level":2,"score":0.41285446286201477},{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.4106791913509369},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3727361857891083},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36924469470977783},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3680538237094879},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.24777764081954956},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2779591629","wikidata":"https://www.wikidata.org/wiki/Q24745328","display_name":"Bradykinin","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000280","descriptor_name":"Administration, Inhalation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020024","descriptor_name":"Leukotriene Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020024","descriptor_name":"Leukotriene Antagonists","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D020024","descriptor_name":"Leukotriene Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058666","descriptor_name":"Adrenergic beta-2 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.2165/11537560-000000000-00000","doi":"https://doi.org/10.2165/11537560-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/11537560-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},{"id":"pmid:20446755","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20446755","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:spr:pharme:v:28:y:2010:i:7:p:597-608","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10.2165/11537560-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:RePEc:wkh:phecon:v:28:y:2010:i:7:p:597-608","doi":null,"is_oa":false,"landing_page_url":"http://PharmacoEconomics.adisonline.com/pt/re/pec/fulltext.00019053-201028070-00007.htm","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/ada2ac94-4ca0-4321-8d1b-24fdd06715dc","doi":null,"is_oa":false,"landing_page_url":"https://research.birmingham.ac.uk/portal/en/publications/cost-effectiveness-of-leukotriene-receptor-antagonists-versus-inhaled-corticosteroids-for-initial-asthma-controller-therapy-a-pragmatic-trial(ada2ac94-4ca0-4321-8d1b-24fdd06715dc).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Wilson, ECF, Sims, EJ, Musgrave, SD, Shepstone, L, Blyth, A, Murdoch, J, Mugford, HM, Juniper, EF, Ayres, J, Wolfe, S, Freeman, D, Gilbert, RFT, Harvey, I, Hillyer, EV & Price, D 2010, 'Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy A Pragmatic Trial', PharmacoEconomics, vol. 28, no. 7, pp. 585-595. https://doi.org/10.2165/11537560-000000000-00000","raw_type":"article"},{"id":"pmh:oai:ueaeprints.uea.ac.uk:15176","doi":null,"is_oa":false,"landing_page_url":"https://ueaeprints.uea.ac.uk/id/eprint/15176/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400384","display_name":"UEA Digital Repository (University of East Anglia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1118541","host_organization_name":"University of East Anglia","host_organization_lineage":["https://openalex.org/I1118541"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.979200005531311,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W162470771","https://openalex.org/W1595046345","https://openalex.org/W1836108609","https://openalex.org/W1964105299","https://openalex.org/W1991285311","https://openalex.org/W1994222210","https://openalex.org/W2012047031","https://openalex.org/W2019258544","https://openalex.org/W2020350342","https://openalex.org/W2022235585","https://openalex.org/W2030556594","https://openalex.org/W2035216610","https://openalex.org/W2039439214","https://openalex.org/W2043990114","https://openalex.org/W2050762912","https://openalex.org/W2062629643","https://openalex.org/W2071686284","https://openalex.org/W2087137161","https://openalex.org/W2098629594","https://openalex.org/W2099765814","https://openalex.org/W2106203584","https://openalex.org/W2106566051","https://openalex.org/W2111855688","https://openalex.org/W2118502261","https://openalex.org/W2119033394","https://openalex.org/W2122433348","https://openalex.org/W2133648331","https://openalex.org/W2139291708","https://openalex.org/W2146960414","https://openalex.org/W2155064155","https://openalex.org/W2172149963","https://openalex.org/W2473786944","https://openalex.org/W2769726248","https://openalex.org/W3135185800","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W7074160851","https://openalex.org/W1550647847","https://openalex.org/W2176039728","https://openalex.org/W4252372035","https://openalex.org/W2020350342","https://openalex.org/W2314596880","https://openalex.org/W2057749991","https://openalex.org/W2209362511","https://openalex.org/W1496980575","https://openalex.org/W2328862247"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}